Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10829	Companies
234909	Keywords
163765	Articles
125736	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 01/22/2026 at 15:00, 6 months 21 days ago

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
Jaguar Health, Inc. provides updates on rare disease program for crofelemer, focusing on intestinal failure treatment milestones, Orphan Drug Designation, and global development efforts

Crofelemer Jaguar Health Orphan Drug Designation Rare Disease Intestinal Failure
BRIEF

published on 01/14/2026 at 15:05, 6 months 29 days ago

Jaguar Health présentera ses services au Lytham Partners Healthcare Summit

Crofelemer Jaguar Health Présentation Virtuelle Médicaments Gastro-intestinaux Sommet Sur Les Soins De Santé
BRIEF

published on 01/14/2026 at 15:05, 6 months 29 days ago

Jaguar Health to Present at Lytham Partners Healthcare Summit

Crofelemer Virtual Presentation Jaguar Health Healthcare Summit Gastrointestinal Medicines
PRESS RELEASE

published on 01/14/2026 at 15:00, 6 months 29 days ago

Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts
Jaguar Health announces virtual presentation by CEO Lisa Conte at Lytham Partners Healthcare Investor Summit. Company focuses on developing plant-based medicines for gastrointestinal distress

Gastrointestinal Distress Virtual Presentation Jaguar Health Lisa Conte Plant-based Medicines
BRIEF

published on 01/12/2026 at 15:05, 7 months ago

Jaguar Health conclut un accord de licence américain avec Future Pak pour Crofelemer

Crofelemer Jaguar Health Future Pak Contrat De Licence Américain Pipeline Des Maladies Rares
BRIEF

published on 01/12/2026 at 15:05, 7 months ago

Jaguar Health Secures U.S. License Deal with Future Pak for Crofelemer

Crofelemer Jaguar Health Future Pak U.S. License Agreement Rare-disease Pipeline
PRESS RELEASE

published on 01/12/2026 at 15:00, 7 months ago

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million
Jaguar Health, Inc. enters U.S. licensing agreement with Future Pak, LLC for exclusive marketing rights of Mytesi® and Canalevia®-CA1, securing $18M upfront payment and potential $20M in milestone payments

Licensing Agreement Jaguar Health Canalevia-CA1 Mytesi Future Pak
BRIEF

published on 01/06/2026 at 15:05, 7 months 6 days ago

Le crofelemer de Jaguar Health se révèle prometteur dans le traitement de l'insuffisance intestinale.

Crofelemer Jaguar Health Étude Pédiatrique Insuffisance Intestinale Soutien Parentéral
BRIEF

published on 01/06/2026 at 15:05, 7 months 6 days ago

Jaguar Health's Crofelemer Shows Promise in Intestinal Failure Treatment

Crofelemer Jaguar Health Intestinal Failure Parenteral Support Pediatric Study
PRESS RELEASE

published on 01/06/2026 at 15:00, 7 months 6 days ago

Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication
Jaguar Health announced groundbreaking results from ongoing proof-of-concept study of crofelemer in pediatric patients with intestinal failure, showing significant reduction of parenteral support (PS) and potential to save lives

Crofelemer Jaguar Health Pediatric Patients Intestinal Failure Parenteral Support

Accesswire

Published on 08/13/2026 at 00:30, 1 hour 42 minutes ago

Aton Closes CAD$4 Million Private Placement
Published on 08/12/2026 at 23:30, 2 hours 42 minutes ago

CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 2 hours 42 minutes ago

Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 2 hours 52 minutes ago

RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 3 hours 7 minutes ago

Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 02:00, 12 minutes ago

A New Category Is Emerging in the Premium Residential Market — the 'Presidence'
Published on 08/13/2026 at 01:05, 1 hour 7 minutes ago

Pepperstone Appoints New CTO to Drive AI-Native Proprietary Tech Push
Published on 08/12/2026 at 21:05, 5 hours 7 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 6 hours 15 minutes ago

EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 6 hours 34 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged

Les Echos

Published on 08/11/2026 at 17:45, 1 day 8 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 8 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 8 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 8 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 8 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE